The demonization of cholesterol and saturated fat was partly driven by industry. Procter & Gamble (Crisco makers) were major AHA funders. The food industry promoted the fat-heart disease narrative, opening markets for low-fat processed foods and $30B+ annual statin sales. Growing evidence suggests sugar, inflammation, and high-carb diets are greater culprits. The sugar industry's 1967 Harvard study was foundational to the misdirection. Some cardiologists now challenge the conventional cholesterol hypothesis entirely.
“The war on cholesterol was a corporate-manufactured crisis. The statin industry, seed oil companies, and processed food manufacturers all profited from demonizing saturated fat.”
From “crazy” to confirmed
The Claim Is Made
This is the moment they called it crazy.
When Dr. Ancel Keys presented his "Seven Countries Study" in the 1950s, he fundamentally reshaped how America understood heart disease. His work established a simple equation: saturated fat causes high cholesterol, which causes heart attacks. This hypothesis became medical dogma, and the American Heart Association built its entire dietary framework around it. For decades, Americans were told to fear butter, eggs, and red meat while embracing vegetable oils and low-fat processed foods.
What most people didn't know was who was funding this narrative. Procter & Gamble, the company that invented Crisco and stood to profit enormously from a shift toward vegetable oils, was a major financial contributor to the American Heart Association. The company that made money selling low-fat alternatives also helped shape the scientific institutions guiding public health. It was a subtle but powerful alignment of interests.
The official response to anyone questioning this framework was swift dismissal. Mainstream cardiology treated the fat-heart disease hypothesis as settled science, not worthy of serious debate. Researchers who published contrary findings found their work marginalized. Medical schools taught the cholesterol-centric model as established fact. Challenging it meant professional risk.
But the cracks in this narrative have been growing for years. The CDC's own resources now acknowledge that the relationship between saturated fat and heart disease is more complicated than once believed. Research published in peer-reviewed journals has shown that inflammation and metabolic dysfunction may be far greater risk factors than cholesterol levels themselves. Some of the most rigorous meta-analyses have found minimal correlation between saturated fat consumption and cardiovascular death.
Meanwhile, the 1967 Harvard study that blamed dietary fat while conveniently exonerating sugar has become a case study in industry influence. Documents show the sugar industry funded that research specifically to redirect attention away from their product. The conclusion was predetermined, the science shaped accordingly. And the public paid the price—both in health outcomes and dollars.
Get the 5 biggest receipts every week, straight to your inbox — plus an exclusive PDF: The Top 10 Conspiracy Theories Proven True in 2025-2026. No spam. No agenda. Just the papers they couldn't hide.
You just read "The cholesterol-heart disease link was promoted by industry …". We send ones like this every week.
No one's said anything yet. Be the first to drop your take.
The statin market now generates over $30 billion annually. While these drugs help some patients, the aggressive expansion of their use correlates directly with the cholesterol hypothesis becoming mainstream dogma. Marketing campaigns made millions of Americans believe their cholesterol was a crisis requiring pharmaceutical intervention. Some of that treatment was necessary. Some was arguably pharmaceutical companies capitalizing on fear they helped create.
This isn't to say cholesterol is irrelevant or that statins have no place in medicine. It's to acknowledge that the cholesterol-centric narrative may have distracted us from more important factors: processed food consumption, refined carbohydrates, sedentary lifestyles, and metabolic inflammation. We may have been vilifying the wrong nutrient while the actual culprits operated in plain sight.
The real question is why this took so long to acknowledge. When industries with billions of dollars at stake help fund the very institutions shaping public health guidelines, conflicts of interest become invisible. They calcify into consensus. They become synonymous with science itself.
This case demonstrates something crucial: institutional capture doesn't require conspiracy. It simply requires aligned incentives. Companies didn't need to orchestrate a cover-up. They just needed to fund the research that supported their interests, and let normal institutional processes do the rest. For millions of people who changed their diets based on incomplete science, understanding how this happened matters more than ever.
